Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Glatiramer Acetate Treatment Increases Stability of Spinal Synapses and Down Regulates MHC I during the Course of EAE

Texto completo
Autor(es):
Scorisa, Juliana M. [1] ; Freria, Camila M. [1] ; Victorio, Sheila C. [1] ; Barbizan, Roberta [1] ; Zanon, Renata G. [1, 2] ; Oliveira, Alexandre L. R. [1]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Estadual Campinas, Inst Biol, Dept Anat Cell Biol Physiol & Biophys, Campinas, SP - Brazil
[2] UFU, Human Anat Sect, Dept Morphol, Campus Umuarama - Brazil
Número total de Afiliações: 2
Tipo de documento: Artigo Científico
Fonte: International Journal of Biological Sciences; v. 7, n. 8, p. 1188-1202, 2011.
Citações Web of Science: 7
Resumo

The recent discovery that the major histocompatibility complex of class I (MHC I) expression has a role in the synaptic elimination process, represented an insight into understanding the cross talk between neurons. In the present study, the possibility that glatiramer acetate (GA) treatment influences the MHC class I expression and the synaptic plasticity process in the spinal cord during the course of EAE was investigated. C57BL/6J mice were induced to EAE and submitted to treatment either with a placebo solution or with GA (0.05mg/animal, subcutaneously, on a daily basis). All the animals were sacrificed at the peak disease (14 days after induction) or at the point of recovery of the clinical signs (21 days after induction). The spinal cords were removed and submitted to immunohistochemical examination, Western blotting and transmission electron microscopy analysis. The results showed that GA treatment was able to decrease synaptic loss during the course of EAE, which correlates with the downregulation of the MHC I complex. The present results reinforce the neuroprotective role of GA treatment, by reducing synaptic loss during the course of the disease. Such action may be associated with the recently described role of MHC I regulation during the synaptic plasticity process. (AU)

Processo FAPESP: 11/18991-8 - Glatiramer acetate treatment increases stability of spinal synapses and down regulates MHC I during the course of EAE
Beneficiário:Alexandre Leite Rodrigues de Oliveira
Modalidade de apoio: Auxílio à Pesquisa - Publicações científicas - Artigo